众兴菌业完成四川众兴股权受让 全资控股提速西南食药用菌基地建设

Core Viewpoint - Tianshui Zhongxing Mushroom Industry Technology Co., Ltd. has completed the acquisition of a 29% stake in its subsidiary Sichuan Zhongxing Mushroom Industry Technology Co., Ltd., increasing its ownership from 71% to 100% [1][2] Group 1: Transaction Details - The acquisition was approved during the 22nd meeting of the fifth board of directors on February 3, and the business registration change has been completed [1] - Sichuan Zhongxing was established on July 9, 2025, with a registered capital of 50 million yuan, serving as a core platform for the company's expansion into the southwestern market [1] Group 2: Project Investment - The total investment for the Southwestern Medicinal and Edible Mushroom Industrial Park project is approximately 700 million yuan, with the first phase requiring about 500 million yuan [1] - The first phase will focus on upgrading existing facilities and developing a factory-based cultivation project for Cordyceps sinensis and other rare medicinal mushrooms [1] - The second phase will involve an additional investment of around 200 million yuan to enhance and support the first phase [1] Group 3: Strategic Implications - The full ownership aims to optimize the group's management structure, enhance decision-making efficiency, and accelerate the implementation of the southwestern base project [2] - This move aligns with the company's strategy of establishing a production base in the northwest while targeting national and global markets, focusing on the development of various mushroom species [2] - The acquisition is expected to strengthen synergies among the company and its subsidiaries, improving overall operational capabilities and competitiveness [2]